Efficacy of Mirabegron Add-on Therapy to Oxybutynin for BPH Patients with Persistent Urgency on Oxybutynin Alone
DOI:
https://doi.org/10.61841/5kev1g98Keywords:
Mirabegron, Therapy, Oxybutynin, BPHAbstract
Aims: To compare the efficacy of mirabegron add-on therapy for persistent overactive bladder (OAB) symptoms despite oxybutynin monotherapy in men with irritative lower urinary tract symptoms suggestive of benign prostatic hyperplasia Methods: 50 patients with persistent irritative lower urinary tract symptoms despite Ditropan monotherapy were randomized to receive add-on therapy with mirabegron (50 mg/day) for 3 months. Improvement in IPSS score and QOL were assessed in patients before and after addition of mirabegron at 3 months Result: From September 2018 to December 2019, 50 patients were enrolled in this study. 38 out of 50 patients got improvement in quality of life (QOL) score. The IPSS score had a mean improvement from 16.6 before the addition of mirabegron to 12.68 after 12 weeks of mirabegron addition. Conclusions: In our study, we noticed that the add-on mirabegron for patients already on anticholinergic drugs but still with persistent irritative LUTS had a good impact on IPSS score and QOL.
Downloads
Published
Issue
Section
License
Copyright (c) 2020 AUTHOR
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
